<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02589002</url>
  </required_header>
  <id_info>
    <org_study_id>1544</org_study_id>
    <nct_id>NCT02589002</nct_id>
  </id_info>
  <brief_title>Effects of Sucralose on Glucose Metabolism</brief_title>
  <acronym>Sucralose</acronym>
  <official_title>Effects of Sucralose on Insulin Sensitivity, Pancreatic Response and Appetite Regulating Hormones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the effects of sucralose on insulin sensitivity, beta-cell response and
      appetite regulating hormones will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The consumption of non-nutritive sweeteners has a high prevalence. The effect of
      non-nutritive sweeteners in both beta-cell function and insulin resistance it is unknown.

      Previous studies performed in animal models and humans with diverse characteristics have
      shown variable effects of different non-nutritive sweeteners in variables related to glucose
      metabolism.

      Due to the high consumption of non-nutritive sweeteners it is relevant to know its effect in
      beta cell-function and insulin sensitivity.

      In this study the effects of sucralose, a non-nutritive sweetener that is highly consumed in
      the population, on insulin sensitivity and beta-cell function will be evaluated.

      54 participants with normal glucose tolerance, normal weight, and without chronic diseases
      with a low consumption of non-nutritive sweeteners will be included. The participants will be
      randomly assigned to consume sucralose or to a control group.

      During the first visit an oral glucose tolerance test with 75 g of glucose will be performed.
      Fasting and 2-hour glucose will be measured in order to rule-out diabetes, abnormal fasting
      glucose, or glucose intolerance.

      During the second visit a three-hour IV glucose tolerance test will be performed
      administering 0.3 g/kg of glucose and insulin 0.03 U/kg. Samples will be taken following the
      minimal model described by Bergman.

      After this visit, the group assigned to receive sucralose will ingest 15% of the adequate
      daily intake (ADI) of sucralose and the control group will abstain of any non-nutritive
      sweetener consumption during 14 days. At the end of this period a third visit to repeat the
      IV glucose tolerance test will be performed.

      Samples will be analyzed measuring glucose and insulin concentrations to evaluate acute
      insulin response (AIR), glucose effectiveness (SG), first phase pancreatic response (ф1), and
      second phase pancreatic response (ф2). In addition, hormones involved in appetite and satiety
      (leptin, ghrelin, and peptide tyrosine tyrosine) will be quantified at the beginning and end
      of the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>Two weeks</time_frame>
    <description>Insulin sensitivity and pancreatic response estimated with the minimal model using a frequently sampled IV glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucagon like peptide (GLP-1) change</measure>
    <time_frame>Two weeks</time_frame>
    <description>Change in fasting GLP-1 after sucralose ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ghrelin change</measure>
    <time_frame>Two weeks</time_frame>
    <description>Change in fasting ghrelin after sucralose ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tyrosine-tyrosine peptide (PYY) change</measure>
    <time_frame>Two weeks</time_frame>
    <description>Change in fasting PYY after sucralose ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leptin change</measure>
    <time_frame>Two weeks</time_frame>
    <description>Change in fasting leptin after sucralose ingestion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Glucose Metabolism Disorders</condition>
  <arm_group>
    <arm_group_label>Sucralose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of 15% of the ADI of sucralose daily during two weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Absence of sucralose ingestion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucralose</intervention_name>
    <arm_group_label>Sucralose</arm_group_label>
    <other_name>Non-nutritive sweetener</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both genders

          -  age between 18 and 55 years

          -  body mass index ≥18.5 and &lt;25 kg/m2

          -  low consumption of non-nutritive sweeteners

        Exclusion Criteria:

          -  diabetes or glucose intolerance

          -  consumption of medications affecting insulin sensitivity (metformin, steroids, hormone
             replacement therapy, contraceptives)

          -  intestinal disease such as malabsorption or previous intestinal resection

          -  history of bariatric surgery

          -  pregnancy or lactation

          -  weight loss greater than 5% in the previous month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paloma Almeda-Valdes, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Attending Physician</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</name>
      <address>
        <city>Mexico City</city>
        <state>Distrito Federal</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.</citation>
    <PMID>25231862</PMID>
  </reference>
  <reference>
    <citation>Brown RJ, Walter M, Rother KI. Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care. 2012 May;35(5):959-64. doi: 10.2337/dc11-2424. Epub 2012 Mar 12.</citation>
    <PMID>22410815</PMID>
  </reference>
  <results_reference>
    <citation>Pepino MY, Tiemann CD, Patterson BW, Wice BM, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013 Sep;36(9):2530-5. doi: 10.2337/dc12-2221. Epub 2013 Apr 30.</citation>
    <PMID>23633524</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sucralose</keyword>
  <keyword>insulin sensitivity</keyword>
  <keyword>beta-cell response</keyword>
  <keyword>appetite regulating hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

